Vaishali Pharma Limited
₹8.77
+2.33%
Delayed · cached 15 min
Fair value analysis
VAISHALI
Vaishali Pharma Limited
₹8.57
Close used for this calculation
₹6.56Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
30/100
Quality radar
Consensus fair value
₹6.56
Above FV▼ -23.5% against the close used
Model range ₹2.33 – ₹11.42
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹2.33Fair value₹6.56Bull₹11.42
FairClose
52-week traded range
52W low ₹4.8852W high ₹12.24
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Vaishali Pharma Limited closed at ₹8.57, 30.6% above the consensus fair value of ₹6.56 drawn from 6 valuation models.
Financial DNA score 30/100 — Weak. P/E of 25.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹6.00
-30.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
₹11.42
+33.3%
EPS × 35.7x (sector P/E)
EPS=0.32, Sector P/E=35.7x
EV/EBITDA
₹2.33
-72.8%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=50M
Book Value (P/B)
₹2.39
-72.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=5.53, ROE=6%, g=3%, r=10%
Reverse DCF
₹8.57
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.1% | Historical: 0%
Margin of Safety
₹6.53
-23.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=8.71, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.